Refining the asymptotically correct standardization of person‐fit statistics for mixed‐format tests
British Journal of Mathematical and Statistical Psychology · 20.04.2026
DOI: 10.1111/bmsp.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Mathematical and Statistical Psychology, online erschienen am 20.04.2026. Verfasst von Sandip Sinharay. Beteiligte Einrichtung: ETS Research Institute, Princeton, New Jersey, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Sinharay ( Psychometrika , 2016, 81, 992) suggested the asymptotically correct standardized version of a class of person‐fit statistics for mixed‐format tests. This paper provides an alternative and arguably simpler derivation of the standardization. The derivation leads to several benefits including a simpler formula of the (asymptotically correct) standardized person‐fit statistics and a theoretical explanation of simulation results reported in literature on person‐fit statistics. This paper promises to make several person‐fit statistics for mixed‐format tests more accessible to researchers and practitioners.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ETS Research Institute, Princeton, New Jersey, USA.
ORCID-Profile: Sandip Sinharay
Zitieren
APA
Sinharay, S. (2026). Refining the asymptotically correct standardization of person‐fit statistics for mixed‐format tests. British Journal of Mathematical and Statistical Psychology. https://doi.org/10.1111/bmsp.70049
Vancouver
Sinharay S. Refining the asymptotically correct standardization of person‐fit statistics for mixed‐format tests. British Journal of Mathematical and Statistical Psychology. 2026. doi:10.1111/bmsp.70049
BibTeX
@article{Sinharay2026,
author = {Sinharay, Sandip},
title = {Refining the asymptotically correct standardization of person‐fit statistics for mixed‐format tests},
journal = {British Journal of Mathematical and Statistical Psychology},
year = {2026},
doi = {10.1111/bmsp.70049}
}
EUVIMED